Terminated NCT03149107
This study has public registry information. It focuses on schizophrenia and currently lists study information in Germany.
Multiple locations, including Mannheim Schizophrenia Other From 18 Years to 40 Years
Countries Germany
Sponsor University Hospital, Bonn
Condition Schizophrenia Completed NCT07379996
This study is completed. It focuses on mental health and currently lists study information in Spain.
In Cartagena Mental health Other Over 16 Years
Countries Spain
Sponsor Alejando Vargas Rubio
Condition Mental health Completed NCT03888391
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In Los Angeles ADHD Other From 8 Years to 13 Years
Countries United States
Sponsor James McGough
Condition ADHD Completed NCT00145470
This study is completed in Global. It is testing safety/Efficacy of Asenapine When Added to Lithium/Valproate for Bipolarity.
In Global Bipolarity Other Over 18 Years
Countries Global
Sponsor Organon and Co
Condition Bipolarity Completed NCT00223496
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In San Antonio Bipolarity, Depression Other From 18 Years to 75 Years
Countries United States
Sponsor The University of Texas Health Science Center at San Antonio
Condition Bipolarity, Depression Completed NCT04283188
This study is completed. It focuses on bipolarity and currently lists study information in Canada.
In Toronto Bipolarity Other From 14 Years to 21 Years
Countries Canada
Sponsor Sunnybrook Health Sciences Centre
Condition Bipolarity Terminated NCT03110575
This study was terminated in the United States. It is testing TNX-102 SL for PTSD.
Multiple locations, including Phoenix PTSD Drug i A study involving a medication or substance. From 18 Years to 75 Years
Countries United States
Sponsor Tonix Pharmaceuticals, Inc.
Condition PTSD Completed NCT02363738
This study is completed. It focuses on bipolarity and currently lists study information in Canada and the United States.
Multiple locations, including Palo Alto Bipolarity, Depression Other From 18 Years to 65 Years
Countries United States, Canada
Sponsor University Health Network, Toronto
Condition Bipolarity, Depression Terminated NCT02389712
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In Rochester Bipolarity, Depression Other From 18 Years to 65 Years
Countries United States
Sponsor Mayo Clinic
Condition Bipolarity, Depression Completed NCT06880328
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Glendale Schizophrenia Other From 18 Years to 50 Years
Countries United States
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT03902613
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In New York Bipolarity, Depression Other From 18 Years to 50 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition Bipolarity, Depression Completed NCT07097025
This study is completed. It focuses on depression and currently lists study information in Israel.
Multiple locations, including Bnei Brak Depression, Bipolarity Other Over 18 Years
Countries Israel
Sponsor Dr.Yoav Domany
Condition Depression, Bipolarity